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Molecular Etiology of Alzheimer's Disease:
Aberrant Splicing of APP Gene Transcript
and Linkage to Apolipoprotein E4 Allele
Seigo Tanaka and Kunihiro Veda
Aberration of alternative splicing of amyloid precursor protein (APP) gene transcript was found in AD brains,
which may cause an imbalance between protease(s) and inhibitor, and possibly lead to deposition of amyloid as a
result of incomplete digestion of APP. The 0:4 allele of apolipoprotein E (APOE) gene was found more
frequently in late-onset cases of AD than in control, indicating that apolipoprotein E4 is a risk factor of AD.
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Figure 1. Structures of APP770 mRNA and four types of APPs
that have structual features of cell surface receptors. The
number of each domain corresponds to that of exon in the APP
gene. Exon 7 encodes the KPI domain.
high ratio of (APP770 mRNA + APP751 mRNA)/
APP695 mRNA.
In this study, we analysed, by the method of RNase
protection assay, the proportion of APP mRNAs in
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APpnOmRNAAlzheimer's disease (AD) is one of the most common
cause of dementia, and pathologically characterized by
the deposition of f3A4 protein in senile plaque cores and
cerebral vessels as amyloid. The f3A4 protein is gener-
ated from larger precursors (amyloid precursor proteins;
APPs) that have structual features of cell surface
receptors (Fig. 1). Three (or reportedly four) types of
APP mRNA [APP770, APP751, (APP714) and APP695
mRNAs] are produced from a single gene transcript by
alternative splicing of exons 7 and 8. The former exon
encodes a Kunitz-type serine protease inhibitor (KPI)
domain; APP770 and APP751, but not APP695 (nor
APP714), have this KPI domain in the extra-cellular
region. Our previous study [1] showed that the
proportion of APP770 mRNA (or APP770 mRNA+
APP751 mRNA) is higher in the brain of AD than in
control, particularly in the cerebral cortex and
hippocampus. Additionally, AD patients showing
histologically a high density of senile plaques exhibited a
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Figure 2. The ratio of (APP770 mRNA +APP751 mRNA)/
APP695 mRNA in the frontal cortex in various neurological
disorders and control. MID: multi-infarct dementia, PD:
Parkinson's disease, ALS: amyotrophic lateral sclerosis.
* p<0.05 (Student's t-test).
Figure 3. Correlation between the ratio of (APP770
mRNA+APP751 mRNA)/APP695 mRNA in the frontal cortex
and age. The regression line for AD group (0, n= 10) is
y=0.005x+0.014 (r=0.372), and that for non-AD group (*,
n=33) is y=0.004x-0.037 (r=0.486). The L90% confidence
areas are indicated with shadowing. The AD group includes
AD and mixed-type dementia.
between the ratio (y) and age (x) both in AD and non-AD
groups (Fig. 3). The relationship between the ages of
AD (XAD) and non-AD (Xnon-AD) giving the same ratio
was XAD =0.8Xnon-AD -10.2, indicating that the AD brain
reached the same ratio of KPI-harboring to lacking APP
mRNAs more than 20 years earlier than the non-AD
brain in senescence. This age-related change of APP
mRNAs proportion is prominent in the gray matter of
cerebral cortex, where senile plaques abound, compared
with the white matter [3]. These findings led us to the
idea that an imbalance between protease(s) and inhibitor,
caused by the aberrant splicing of APP gene transcript,
may perturb normal degradation of APPs, thereby
leading to deposition of (JA4 protein as amyloid. The
proportion of APP mRNAs may serve as a molecular
index of brain aging or a marker of AD.
Apolipoprotein E (apoE) is a structual component of
chylomicron and lipoproteins and plays an important role
in lipid metabolism. There are three major isoforms,
referred to as apoE2, E3 and E4, that are encoded by £2,
c3 and 104 alleles, respectively, of a single gene located on
the long arm of chromosome 19. The 104 allele was
reported to be associated with late-onset familial and
sporadic ADs in the United States [4]. In this study, we
analysed apoE genotypes in Japanese cases of sporadic
AD by using PCR (polymerase chain reaction) coupled
with RFLP (restriction fragment length polymorphism).
We found a significant increase in the frequency of 104
allele in late-onset cases (0.25), but not in early-onset
ones (0.04), compared with control (0.09) [5]. The 104
allele frequency was not so high among Japanese AD
patients as reported for Caucasians, which could explain
the relatively lower morbidity from AD in Japan. Thus,
the apoE 104 allele appears to serve as a risk factor of AD.
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various neurological disorders with special reference to
aging. We found that the ratio of (APP770 mRNA+
APP751 mRNA)/APP695 mRNA increased approxi-
mately 1.5-fold in the frontal cortex of AD compared with
other neurodegenerative or cerebrovascular disorders [2]
(Fig. 2). Furthermore, we found a positive correlation
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